TGI Fridays and Allegro Merger Corp. Announce Updated Details for Conference Call Today
NEW YORK, NY and DALLAS, TX, Nov. 11, 2019 (GLOBE NEWSWIRE) — Privately held TGIF Holdings, LLC (“TGIF” or “Fridays”) […]
Amarin to Present at the Jefferies 2019 London Healthcare Conference
DUBLIN, Ireland and BRIDGEWATER, N.J., Nov. 11, 2019 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company focused on […]
STEYR showcases future farming technology with its STEYR Konzept – a hybrid powered concept tractor
STEYR_ConceptSTEYR has undertaken a study which focuses on zero-emission powertrains, innovative drive solutions and a futuristicoperator environment.London, November 11, [...]
Yiren Digital to Report Third Quarter 2019 Financial Results on November 14, 2019
BEIJING, Nov. 11, 2019 (GLOBE NEWSWIRE) — Yiren Digital Ltd. (NYSE: YRD) (“Yiren Digital” or the “Company”), a leading fintech […]
ASLAN Pharmaceuticals Announces Topline Results From TreeTopp Global Pivotal Study of Varlitinib in Biliary Tract Cancer
– The study did not meet its co-primary endpoints. The primary analysis of PFS yielded a hazard ratio of 0.90 […]
Chi-Med Announces NDA Acceptance in China for Surufatinib in Non-Pancreatic Neuroendocrine Tumors
LONDON, Nov. 11, 2019 (GLOBE NEWSWIRE) — Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) today announces that its New Drug […]
Aurcana Update on Underground Development and Resource Expansion Plans Progress
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, Nov. 11, 2019 (GLOBE […]
Amex Announces Fully Funded 100,000 m Expanded Drill Program on Perron Gold Property in Quebec
MONTREAL, Nov. 11, 2019 (GLOBE NEWSWIRE) — Amex Exploration Inc. (“Amex or the Company”) (TSX-V: AMX, FRA: MX0, OTCQX: AMXEF) […]
Verona Pharma to Participate in Two Upcoming Institutional Investor Conferences in New York
LONDON, Nov. 11, 2019 (GLOBE NEWSWIRE) — Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company […]
GW Pharmaceuticals receives positive NICE recommendation for EPIDYOLEX® (cannabidiol) oral solution for the treatment of seizures in patients with two rare, severe forms of childhood-onset epilepsy
GW also welcomes the positive guideline recommendation for Sativex® (nabiximols) for the treatment of spasticity due to multiple sclerosis as […]
